Suchergebnisse - "Vestbo, Jørgen"

PubPharm (25)

1

Adrenal suppression in patients with chronic obstructive pulmonary disease treated with glucocorticoids : Role of specific glucocorticoid receptor polymorphisms

enthalten in: PloS one | 2022

von Sivapalan, P. | Borresen, S. | Eklöf, J. | +12

2

COVID-19 Clinical Trials : Unraveling a Methodological Gordian Knot

enthalten in: American journal of respiratory and critical care medicine | 2020

von Mathioudakis, A. | Fally, M. | Hashad, R. | +3

3

Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP) : a multicentre, randomised, controlled, open-label, non-inferiority trial

enthalten in: The Lancet. Respiratory medicine | 2019

von Sivapalan, P. | Lapperre, T. | Janner, J. | +18

CommentIn: Lancet Respir Med. 2019 Aug;7(8):647-648. - PMID 31122897

4

Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease

enthalten in: Journal of the American College of Cardiology | 2018

von Adamson, P. | Anderson, J. | Brook, R. | +10

CommentIn: J Am Coll Cardiol. 2018 Sep 4;72(10):1138-1140. - PMID 30165985

5

Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease : the SUMMIT trial

enthalten in: European heart journal | 2018

von Byrd, J. | Newby, D. | Anderson, J. | +9

6

Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE) : a double-blind, parallel group, randomised controlled trial

enthalten in: Lancet (London, England) | 2018

von Papi, A. | Vestbo, J. | Fabbri, L. | +10

CommentIn: Lancet. 2018 Mar 17;391(10125):1003-1004. - PMID 29395271

7

Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation : The SUMMIT trial

enthalten in: Respiratory medicine | 2017

von Crim, C. | Calverley, P. | Anderson, J. | +9

CommentIn: Respir Med. 2017 Oct;131:247-248. - PMID 28867435

8

Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk

enthalten in: Heart (British Cardiac Society) | 2017

von Brook, R. | Anderson, J. | Calverley, P. | +10

9

A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations - The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol

enthalten in: BMC pulmonary medicine | 2017

von Sivapalan, P. | Moberg, M. | Eklöf, J. | +15

10

Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY) : a double-blind, parallel group, randomised controlled trial

enthalten in: Lancet (London, England) | 2017

von Vestbo, J. | Papi, A. | Corradi, M. | +7

CommentIn: Lancet. 2017 May 13;389(10082):1864-1865. - PMID 28385354